LINDSAY MAXWELL: Open Payments
NPI 1467735589 · REDLANDS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 6 payments from 3 companies in 2025. Trend: 2023 $637 · 2024 $180 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $337 |
| Celgene Corporation | 1 | $56 |
| GlaxoSmithKline, LLC. | 1 | $46 |
Products named: SARCLISA, ABECMA, BLENREP.
Industry payments across CA — which companies pay providers there.
